S100A9 expression is significantly higher in a variety of tumours compared to normal tissues or healthy individuals, and may be a potential marker for poor prognosis of cancer patients (Gunaldi et al., 2015; Huang et al., 2018; Shabani et al., 2018; Yun et al., 2015). The gene discussed is S100A9; the disease is neoplasm.